Want to see CCLD full AI Analyst Report?
CCLD Stock Chart & Stats
$2.22
$0.05(2.30%)
At close: 4:00 PM EDT
$2.22
$0.05(2.30%)
Day’s Range― - ―
52-Week Range$2.03 - $4.01
Previous CloseN/A
Volume51.36K
Average Volume (3M)199.58K
Market Cap
$104.96M
Enterprise Value$130.71
Total Cash (Recent Filing)$13.39M
Total Debt (Recent Filing)$54.01M
Price to Earnings (P/E)35.4
Beta1.90
Next Earnings
Oct 29, 2026EPS Estimate
0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding42,493,860
10 Day Avg. Volume164,695
30 Day Avg. Volume199,584
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)2.08
Price to Sales (P/S)1.03
P/FCF Ratio6.03
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$5.25Price Target Upside136.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.21
Revenue Forecast (FY)$131.25M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue GrowthStrong growth alongside a rising recurring mix improves revenue visibility and customer retention economics. A larger subscription and technology-enabled base can support more predictable cash generation and create opportunities to cross-sell services.
Profitability And Cash GenerationSustained GAAP profitability and positive free cash flow indicate that the business model is converting operations into funding. This supports product investment, acquisition integration and debt servicing without relying solely on external capital.
AI And Compliance ExpansionEntering compliance and audit defense broadens CareCloud's addressable market and adds a potential recurring SaaS stream. Combining acquired expertise with AI and the existing provider base may strengthen differentiation and cross-selling over time.
Bears Say
Balance Sheet VolatilityAlthough current leverage is described as manageable, rising debt and a reduced equity cushion leave less protection against operating setbacks. Historical instability, including the 2023 negative ROE period, suggests capital structure and earnings remain sensitive.
Margin And Profit PressureLower reported profit and gross-margin pressure could limit the benefits of revenue growth if investment and delivery costs remain elevated. R&D, amortization and interest expenses may weigh on earnings until newer products reach sufficient scale.
Execution And Liquidity RiskThe reaffirmed outlook requires a materially stronger second half, successful integrations and timely product deployment. Limited working capital and ongoing Medsphere remediation could reduce flexibility if sales, implementation or cost targets slip.
CareCloud News
CCLD FAQ
What was Carecloud, Inc.’s price range in the past 12 months?
Carecloud, Inc. lowest stock price was $2.03 and its highest was $4.01 in the past 12 months.
What is Carecloud, Inc.’s market cap?
Carecloud, Inc.’s market cap is $104.96M.
When is Carecloud, Inc.’s upcoming earnings report date?
Carecloud, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 70 days.
How were Carecloud, Inc.’s earnings last quarter?
Carecloud, Inc. released its earnings results on Aug 06, 2026. The company reported $0 earnings per share for the quarter, missing the consensus estimate of $0.023 by -$0.023.
Is Carecloud, Inc. overvalued?
According to Wall Street analysts Carecloud, Inc.’s price is currently Undervalued.
Does Carecloud, Inc. pay dividends?
Carecloud, Inc. does not currently pay dividends.
What is Carecloud, Inc.’s EPS estimate?
Carecloud, Inc.’s EPS estimate is 0.1.
How many shares outstanding does Carecloud, Inc. have?
Carecloud, Inc. has 42,493,860 shares outstanding.
What happened to Carecloud, Inc.’s price movement after its last earnings report?
Carecloud, Inc. reported an EPS of $0 in its last earnings report, missing expectations of $0.023. Following the earnings report the stock price went down -8.661%.
Which hedge fund is a major shareholder of Carecloud, Inc.?
Currently, no hedge funds are holding shares in CCLD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareCloud Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.25 (136.49% Upside)
$5.25 (136.49% Upside)
Blogger Sentiment
Bullish
CCLD Sentiment 100%
Sector Average 62%
Sector Average 62%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.9%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.97%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
24.73%
Trailing 12-Months
Company Description
Carecloud, Inc.
CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities into two core divisions: Healthcare IT and Medical Practice Management. Through its Software-as-a-Service (SaaS) platform, CareCloud provides essential tools for managing revenue cycles, administering practices, handling electronic health records, gleaning business insights, facilitating telehealth, and enhancing patient engagement. These offerings, complemented by various software utilities and tailored business services, are designed to empower diverse medical groups and health systems. Professionals such as doctors, nurses, physician assistants, and other clinical staff who render billable services are among its key users. Established in 1999 and based in Somerset, New Jersey, the entity was originally named MTBC, Inc. before officially adopting CareCloud, Inc. in March 2021.
CCLD Company Deck
CCLD Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a constructive, strategic story: solid top-line growth (+16% Q2, +15% H1), a growing recurring revenue mix, continued GAAP profitability streak, a cleaner capital structure after fully redeeming Series B, and clear progress on AI and a new compliance SaaS initiative. Near-term reported profitability and some cash metrics are pressured by deliberate investment choices — accelerated R&D expense, acquisition-related amortization, and higher interest — and by integration work (notably Medsphere). Management reaffirmed guidance and expects a stronger second half as investments convert to scale. Overall, positives (revenue/regional trends, recurring revenue expansion, capital structure improvement, AI/product milestones, new market entry) outweigh the near-term headwinds driven by strategic investments and integration costs, but execution risk remains.View all CCLD earnings summariesCCLD Stock 12 Month Forecast
Average Price Target
$5.25
▲(136.49% Upside)
Technical Analysis
Ownership Overview
2.32% Insiders
6.25% Mutual Funds
6.16% Other Institutional Investors
78.82% Public Companies and
Individual Investors